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higher pressure inflation (each time by 1 atmosphere) until perfect balloon
dilatation is achieved (12 cycles). CAPSID was used in 146 vessels, (126
I@: 80% Ofprocedures were pain-free with a Iowdissecfion rate(7%type B
and 2% type C) and only 2% needed stent implantation. At 6-mo follow-up,
only 26% of pts had mild angina or a positive atress test, 12% angiographic
restenosis and only 9% needed repeat PTCA.
Preesura-volume curves obtained by CAPSID demonstrate mechanisms
of PTCA: stretching (parallel lines shifting to the right) vs. breaking atheroma
(abrupt break in curve). In 31 pts who had a aecond angiogrsm - a break in
curve had a 74Y0sensitivity and 100% Specificityfor predicting no restenosis.
Thus, CAPSID allows safer PTCA with less pain and dissections, de-
creased need for stanting, and leas rastenosis. The pressure-volume cui-ves
reflect PTCA mechanisms, may predict restenosis and direct strategies to
prevent it.
1928-11I lntewentlonal Device Slzing:On Line QCAvs.
Visual Assessment
E.V. Pomerantsev, C.P.Juergens, J..Nee, A.C. Yaung, S.N. Oesterfe,
P.J. Fitzgerald, S.H. Steftzer. Stanford University Hospita/, Stanford, CA,
USA
Toasseasthe adequacy of interventional device sizing, we imaged non com-
pliant coronary balloons of 3.25, 3.5, 3.75 and 4.0 mm during inflation with
diluted contraat to 3,8, 12 and 16 ATM. The images of 17 precision drilled
lesion phantoms filled with Omnipaque, and of balloons, were acquired on
Philips Itegris syatern andon cinefilm in 5 inch II mode, at 70 kV. High resolu-
tion analog video images were csptured using Pentium PC workstation, QCA
was performed on line using modified QCA Plus package and off cinefilm in
usual fashion. All images were aasessad by a panel of 3 cardiologists to es-
timate balloon sizeaand phantom reference diameters (D ref). The accuracy
was expressed as the mean signed difference between ‘true” and measured
values, mean absolute difference (MAD) waa used for more detailed assess-
ment of the systematic error. Precision wee defined as a standard deviation
of the measurements.
Amwracy Precision MAD
Balkfon,Psnel,mm 0.4 0.2 0.4
Balloon,OnLineQCA,mm 0.1s 0.12 0.2
Balloon,CineQCA,mm 0.11 0.13 0.1
D ref.,Psnel,mm 0.21 0.5s 0,35
Drsf.,OnLineOCA,mm –0.01 0.05 0.06
D ref., Clne QCA, mm 0.01 0.08 0.07
The accuracy of the on line and cine QCA for D ref and balloon sizing
wee significantly higher than panel estimates (p e 0.01).
Conclusion: Visual device sizing alone results in systematic erroneous
undersizing of intewentional devices, which may adversely affect stent out-
comes.
a92812 OveraizedBalloons,LowInflationPreeaureandProlongedCoronsryDilststionStrstegyResultsin
DramaticImprovementsinAngioplastyReeults&
RestenosieRate:Early& LateResults
F.Akhraa, A. Abu Ouaa, M. Rustom. King Fafrd Mi/ifary Hoapita/, Jeddah,
Saudi Arabia, Charing Cross Hospital, London, England
Weproposetoperform coronatyangioplasty (PTCA)using aballooosiza/vessel
diameter ratio of up to 1.2:1, a low inflation pressure and prolonged coronary
dilatation atrategy and to evaluate restenosis rate at nine months (mos). 226
consecutive patients (pts); 170 males and 56 females aged 56 + 10 years
underwent PTCA. Gradual inflation was applied until balloon became fully
expanded followed by a prolonged symptoms-limited dilatation at 4 atm, The
maximum Inflation pressure used waa 5.5 l 1.4 atm (range 2-12) and the
total inflation time was 6.4 + 6.5 min (2.56 mirdinflation). One hundred and
fourteen pts had aingle-veesel disease and 114pta had multivessel disease.
Diameter stenosia (DS) by Quantitative Angiography was 66+ 11%. PTCA
was attempted in 414 lesions (21 lesions were not crossed by the guide
wire because of complete occlusion in 13 pts or aevere stenosis) and was
successful (DS < 30%) in 96Y0of the dilated lesions with a residual DS of 16
+ 10%.There was no abrupt closure and two pts haddissaction that required
bail-out stenting and subsequent CABG. Nine pta had minor dissection that
did not require stenting. Hospital stay was 2.6 * 1.6 days. To-date, 159
(70’7” pts had repeat angiogrsphy and exercise ECG at 9 mos (range 5-29).
~s (> 50% diameter StenOSiS)was found in 31 (19Yo) pts. of these
31 pts, 6 had complate occlusion and 11 pts had repeat PTCA. DS in the
remainder of ptawas 17* 11%.132 pts had pre PTCA Bruce treadmill stress
test; lwat PTCA exercise time to 1 mm ST depression was 7.5 + 2.6 rein,
and maximum ST depression was 0.4+ 0.06 mm compared to pre PTCA of
4.6 + 2.4 min. p c 0.001 and 1.4+ 0.9 mm, p <0.001, respectively. Conc/u-
sions:overaizad balloons with low inflation pressure and prolonged dilatation
strategy haa low complication rate and result in low (19%) restenosis rate at
9 mos. This was associated with a sustained improvement in symptomatic
status and exercise variables, Further studies to compare this strategy with
conventional PTCA are required.
1928-13] Effects oflargedOsesOfCOntraat medium in
complex coronary interventions
1,Buschmann, C.W. Harem, W, Terres, T. Meinertz. University Hospita/
Hamburg, Dept. of Cardiology, Hamburg, Germany
Complex coronary interventions frequently require large amounts of contrast
medium (CM), which are potentially nephrotoxic. There are no data on the
limitations of CM dosages in patients (pts). In order to evaluate the effect of
CM (> 500 ml) on kidney and necrologic function in pts. without known renal
diseases we analyzed a cohort n = 110 consecutive pts. (n =46 PTCA, n =
41 stent, n =21 laserwire recanalization; 64 + 11 years, female 12%, body
weight 74 + 11 kg), who received non ionic CM (Iopamidol 755.2 mg/mgl,
Iopromid 769 mg/ml/median: 570 ml, max: IQOOml). After the procedure pts.
were hydrated with 21000 ml saline infuaions. Blood samples from each
pat. for aerum creatinine and serum urea before, 46 (n= 110) and 72 hours
(n = 40) after intervention were obtained. After the intewantion no renal
or necrologic complications occurad. There were no significant difference
between the serum creatinine and serum urea before and 46iT2 hours after
intervention. None of the pts. had an increase of serum creatinine of more
than 25%.
Ssrum Creatinine(m@dl) Serum Ursa (mg/dl) n
- Baforeintervention1.2 * 0,1 14.7 * 4.1 110
-4S h atterintewsntion 1.3& 0,2 15.3 l3.9 110
-72 h atterintervsntiorr1,1 & 0,3 15,0 * 3,7 40
Conclusion: The application of up to 1000 ml of nonionic CM in wall
hydrated pts. at the commencement of the procedure and without impaired
kidney function did not result in any renal or necrologic dyafuntion. Further
prospective studiea in larger cohorts are neceasaty to evaluate the potential
limits in CM dosing.
-1 Lowlndividua,operatorCoronawlnt.mentional(Cl) Volume Is Not Associated With worse Outcome
L.W. Klein, G.L. Schaer, J.E. Calvin, B. Palvas, J. Allen, E. Urefz,
J.E. Parrillo. Rush Heart /nstitute, Chicago, IL, USA
To aasesa the relationship between individual operator Cl volume and inci-
denceof complications, the in-hospital outcome at a single, moderate volume
urban academic center was prospectively collected over a 3 year period.
1369 consecutive procedures were performed or aupervisad by 9 operators.
25.2% procedures involved multivessel Cl. The mean ejection fraction was
59 + 15%, and there were 1.7 * 0.7 vesaels diseased. Clinical indication
included stable angina 22.5’7’.,unstable angina 31.9%, acute Ml 2.9%, post
Ml 20.6%, shock 3.0%, and restenosis 19.1. There were 20.7% type A,
55.5% type B, and 23.6% type C lesions. Average yearly operator volume
ranged from 26-63 (mean 51 + 26). Operators have performed 590 + 266
Cla, with 10.0 + 4.3 years Cl experience, with a mean angioplasty volume
rating of 160 + 37 (> 170 = adequate). The in-hospital major complication
rate was 1.4Y. (95Y. Cl 0.7-1.69) for all Cl’s, including 2 deaths, 13 CABG,
3 arrhythmias, and 2 Q wave Ml. The rate of complications in this study was
lower than the 1995 SCA&l registry (1.9%, n = 19594, p < 0.05), 1995 ACC
database (3.9%, n = 36963, p = 0.001), Hartzler 1968 (2.3%, n = 5413, p =
0.02), and 1965-1966 NHLBI Registry (7.2%, n = 1601, p = 0.001). Thus,
despite individual volumes below those being considered for credentialing,
the overall outmme obtained wae excellent.
[928-15]Change~inFun~tional~eafthfof’~omenvereus
MenOneYearFollowingPTCAorCABG
D. Malenka, D. Wennberg, L. Lucas, M. Keller, Jr., J. Robb, J. Morton,
W. Nugent, G. O’Connor. Darfmouth-Hitchcock Medics/ Center Lebanon,
NH, USA, Maine Madicsl CenteCPor?land,ME, USA
Previous research has suggested that functional healt~JEki) following PTCA
or CABG ia similar in women and men, but this reae$rch was based on small
numbers of women. Methods: We administered the MOS-SF36 FH instru-
ment to 166 women and 291 men, prior to and one year following their PTCA
or CABG. Baseline data included demographics, dsk factora; comorbidities,
anatomy and symptoma. Repeated meaaures ANOVA was uaed to com-
pare acores by sex, controlling for age, priority, number of diaeaaed veaaela
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and procedure. Rasuks: Women were older, more symptomatic, required
more urgent procedures and had more single vessel disease than men. EF
was similar. At baseline, women reported more bodily pain, poorer physical
and social functioning and leas vitality. However, despite comparable im-
provement on all scales, women continued to report poorer FH, even after
adjustment for differences in baseline characteristics. Conclusion: Men and
women receive similar benefit in FH from revascularization. Because women
present in pcerer FH, they remafn in poorer FH than men at one year post
procedure.
acale Men (291) Women (186)
Prior Post Prior Post
General Health 59.6t 63.0 56.2 57.5*
BodilyPain 51,0 73,5 45.s 66.9*
PhysicalFunoIlon 55.9 72.0 41.1 59.3*
Mental Hsalth 67.1 74.4 63.1 69.4’
Vimlhu 431 57.0 36.2 50.1”
928-16 TheImpactof RaatanosisonCornpariaonaof
Outcomeat OneYaarBetweenAngioplaatyand
BypaaaSurgaty
AS. Kurbaarr,T.J. Bowker, A.F. Rickards. Royal BronrptorIHospitaVNH&L/,
London, UK
PTCA is limit@ by restenosis. We assessed the impact of rsstenosis on one
year outcome rmmparieonsbetween angioplasty (PTCA)and bypass surgety
in the CABRI population.
Meffroc: In 514 patients who underwent PTCA in the CABRI trial, those
that clinically restenosad were identified. Clinical restenosis was defined as
initially successful PTCA followed by a second attempted revascularisation,
b@waan 10-200 days inclusive, either by PTCA at the initial site or by
bypass surgery, at or distal to the original site. Three groups were identified:
Bj’PSSSsurgery (CABG). pTCA with restenosis (RS) or without restenosis
(pT). Comparisons were: PT vs CABG, and PT vs RS. Outcomes assessad
were death, infarction, further ravasculartaations,and angina (CCS grades
1 or 21). Results: In the PTCA population RS = 12%. Death: no difference
between the three groups. Infarction: non-significantly worae in PT vs CABG
(Relative Risk 1.9, Confidence Interval 0.96-S.7, p = 0.064). No infarctions
in the RS group. Further revaacularisation: more common in PT vs CABG
(RR 8.6, Cl 5.14-14.41, p < 0.0C05). No further revascularisations in the RS
group. Angina: worse in PT vs CABG (RR 1.5, Cl 1.01-2.1, p < 0.05) and
also in RS VSPT (RR 2.0, Cl 1.2-3.3, p =0.006).
Conclusion: There remained a worae angina status and greater need for
repeat revascularisation in the PTCA group, deepite excluding those who
raatenoaad. Furthermore, in the PTCA population thosa who restanosad
when compared to those who did not, had a worse angina status, despite a
second ravascularisatiofl procedure.
D92817 CombinadAntiplateletPretreatmentwithAapirin
andTiclopidineReduceaIn-hoapitslCardiac
EventaFollowingElectiveCoronaryAngioplasty
J. vom Dahl, H.G. Klues, T. Reffelmann, F. Hendricks, P.Hanrath. University
Hospital, Aachen, Germany
In 1995, a total of 711 patienta (pts, 76°4 male, ~ + 9 years) with stable
angina pactoris symptoms were treatad electively by PTCA. Multiple vessel
dieaaaa was present in 56Y0,and reduced ventricular function (EF c 45%) in
S2%. PTCA was attempted for type B/C lesions (ACC/AHA classification) in
66°Y0and for restenoaes in 25%.
To shorten the intewal between a possible stent implantation and the
treatment effect of ticlopidine, all pta began antiplatelet therapy with 100 mg
aspirin and 2 x 250 mg ticlopidine ?1 day prior to angioplasty. During PTCA,
116 pta (group A, 16%) had stent implantation (95% Palmaz-Schatz), and
595 pts (group B) were treated by PTCA.only (incl. laser angioplasty and
rotational atheractomy). Stent implantation (1.4 +0.9 stentrdpt)was primarily
planned in 35%, for a Suboptimal PTCA result in 50%, and for a “bail-our
in 15%. Following PTCA, 21,000 NJhepattn/h were given for 24 hrs in both
groups. Pts in group A continued with the combined antiplatelet regimen for3
months followed by aspirin, group B received aspirin only. In-hospital eventa
were compared with 1993/4 (n = 1014, no significantly different patient or
lesion characteristics) without this pretreatment and with 2% stents.
Subacute stent thrombosis (SAT) in group A occured in 1/116 pta with no
SAT following discharge. Thus, combined antiplatelet pretreatment in com-
bination with a more frequent use of stents resulted in significantly reduced
PTCA related cardiac events without an increase of bleeding complication
during hospital stay.
1928-18( lncrea$$fnMeanPlateletVolumeasParameterfor
RestenoaiaFollowingSuccessfulPercutaneous
TransluminalCoronaryAngioplasty
L. Pizzulli, A. Yang, M. Zirbas, A. Hagendorff, B. Luderitz. Departrrrerrfof
Cardiolog~ UniversifyofBonn, Bonn, Germany
Since platelet size and activity correlate, the mean platelet volume (MPV)aaa
marker for platelet function was found to be increased in unstable angina and
myocardial infarction and is a risk factor for future coronary events in patienta
after myocardial infarction. The aim of our study was to assess, whether an
increased MPV 2-4 hours before PTCA influences the restenosis rate. We
studied 116 patients (pat) with either stable (n = 66) or unstable angina (n =
30) referred for single-vessel PTCA. All pat underwent repeat angiography
4-6 months after PTCA regardless of symptoms. Restenosis was defined as
a diameter SW’IOSiS Of> 50Y0 at angiographic fOllOW-Up.
Results:
In stable angina the MPV was significantly lower ea compared to pat with
unstable angina (6.1 + 0.4 fl vs. 6.7 + 0.5 fl; p < 0.01). Pat with restenosis
had a MPV which was significantly Iargercompared to pat with no restenoais
(p c 0.01). The pat with unstable angina who developed a reatenosis hadan
even larger MPV than any other pat subgroup and the restenosis rate in pat
with an MPV of >9 fl was 72%.
Rastenosis No-Rsstenosis
stable unstsble stsble unstable
MPV(rl) 5.5 l 0.4 5.9 * 0.5 8.0 * 0,4 8.3 & 0.7
Conclusion:. An increase in mean platelet volume is a riak factor and
predictor for restenosis following successful PTCA in stable and unstable
angina.
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[929-161 I Responseofthelnts~tLefWantricletohmreaesd
AfterloadDoesnotDependona Concomitant
Increasein’CoronaryPerfusionPreasure
M.K. Karunanithi, J.A. Young, W. Kalnins, M.P. Feneley. St. Vincent’s
Hospital, Sydne~ NSW, Australia
To determine the influence of the normal concomitant increase in corona~
perfusion pressure (CPP) with increased left ventricular (LV) afterload on
LV afterkrad sensitivity, 6 autonomically blocked open-chest dogs were in-
strumented with ultrasonic dimension transducers and micromanometera to
measure LV volume, LV pressure and CPP, respectively. The left main coro-
naty artery was perfused through a cannula with a side gate to the aortic
root. With the gate open, CPP increased in the normal manner with aortic
mnstriction (AC). With the gate closed, CPP waa maintained constant at
100 mmHg despite increased LVpressure with AC. Toquantifythe afterload-
response under each parfusion condition, the end-systolic pressure-volume
Group(n) Osath Ml CABG Re-PTCA Bleeding
A fllal nons 1.7% 2.6%# 0.6% 0.8%.., ...,
s (593) none 0.2% none 0.2% 0.8%
A+ B (711) nons 0.4% 0.4% 0.3% 0.8%
19S3/4 (1014) 0.6% 2.0%” 0.5”4 1.6%” 1%
*pc 0.05vs B, andvs A+ B; #3pts had uncomplicatedCA6G (no Ml) forintracomnsry
sient losswithstent rsmovalduringCABG.
Gate SW-EDV ESPV
slope hrtemspt Slope Intercspt
(erg ml-l 104) (ml) (mmHg ml-l (ml)
Control Open 7.9 i 4.1 18.0+ 13.7 3.8+ 3.0 –1.9 l 11.7
AC Open 7.2 + 5.0 11.3 +21.2 2,9+ 3.3
Control
–29.2&38.l
Closed 8.543.3 20,9 + 12.6 3.6* 2.3 –12.3+ 34.1
AC Closed 7.o + 2.9 fs,7i 9.0 1.6 kO.9 –48.3*2e.9
